Goldman Sachs’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $63.7M | Buy |
|
|||||
|
2023
Q3 | $5.96M | Sell |
|
|||||
|
2023
Q2 | $20.4M | Sell |
|
|||||
|
2023
Q1 | $30.2M | Sell |
|
|||||
|
2022
Q4 | $37.8M | Buy |
|
|||||
|
2022
Q3 | $35.1M | Sell |
|
|||||
|
2022
Q2 | $23.6M | Buy |
|
|||||
|
2022
Q1 | $19.3M | Buy |
|
|||||
|
2021
Q4 | $19.8M | Sell |
|
|||||
|
2021
Q3 | $18.6M | Sell |
|
|||||
|
2021
Q2 | $19.9M | Buy |
|
|||||
|
2021
Q1 | $17.9M | Buy |
|
|||||
|
2020
Q4 | $14.7M | Buy |
|
|||||
|
2020
Q3 | $7.11M | Buy |
|
|||||
|
2020
Q2 | $3.87M | Buy |
|
|||||
|
2020
Q1 | $1.17M | Buy |
|
|||||
|
2019
Q4 | $1.19M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.53M | Buy |
|